Tower Research Capital LLC (TRC) - TANDEM DIABETES CARE INC ownership

TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 4 filers reported holding TANDEM DIABETES CARE INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of TANDEM DIABETES CARE INC
ValueSharesWeighting
Q3 2023$139,014
-69.4%
6,693
-63.9%
0.00%
-73.3%
Q2 2023$454,358
+15145166.7%
18,515
+23637.2%
0.02%
Q1 2023$3
-95.2%
78
-94.5%
0.00%
-100.0%
Q4 2022$63
-100.0%
1,412
-85.5%
0.00%
-62.5%
Q3 2022$467,000
-26.0%
9,754
-8.5%
0.01%
-42.9%
Q2 2022$631,000
-46.8%
10,660
+4.4%
0.01%
+27.3%
Q1 2022$1,187,000
+19.7%
10,207
+54.8%
0.01%
-35.3%
Q4 2021$992,000
+147.4%
6,595
+96.3%
0.02%
+70.0%
Q3 2021$401,000
+157.1%
3,359
+109.3%
0.01%
+150.0%
Q2 2021$156,000
-57.5%
1,605
-61.5%
0.00%
-33.3%
Q1 2021$367,000
-56.8%
4,164
-53.1%
0.01%
-76.9%
Q4 2020$849,000
-21.7%
8,879
-7.0%
0.03%
+116.7%
Q3 2020$1,084,000
+42.6%
9,548
+24.4%
0.01%
-61.3%
Q2 2020$760,000
+87.7%
7,676
+13.0%
0.03%
-8.8%
Q4 2019$405,000
+148.5%
6,792
+145.9%
0.03%
+209.1%
Q3 2019$163,000
+52.3%
2,762
+63.3%
0.01%
+83.3%
Q1 2019$107,000
+5250.0%
1,691
+2584.1%
0.01%
Q4 2018$2,000
-98.2%
63
-97.5%
0.00%
-100.0%
Q3 2018$109,0002,5410.01%
Other shareholders
TANDEM DIABETES CARE INC shareholders Q4 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 474,929$22,725,0003.92%
Soleus Capital Management, L.P. 415,200$19,867,0002.70%
First Light Asset Management, LLC 485,620$23,237,0002.35%
Eagle Health Investments LP 196,400$9,398,0002.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 218,049$10,434,0001.66%
EMINENCE CAPITAL, LP 1,590,787$76,119,0001.59%
Brown Capital Management 2,010,230$96,190,0001.35%
Chicago Capital, LLC 479,873$22,962,0001.33%
Intrinsic Edge Capital Management LLC 247,391$11,838,0001.29%
Bellevue Group AG 1,566,015$74,933,0001.08%
View complete list of TANDEM DIABETES CARE INC shareholders